Movement Alert｜ImmunityBio, Inc. Rises 5.05% in Regular Trading, Biotechnology Sector Gains on Broad Strength

Market Focus

Oct 09

On October 9, ImmunityBio, Inc. rose 5.05% in regular trading, trading at $10.41/share, with turnover of $16.54 million.

Within the Biotechnology sector where ImmunityBio, Inc. belongs, the overall sector change is positive. Among individual stocks, Moderna up 8.78%, Twist Bioscience up 6.81%, AbbVie up 1.08%, Gilead Sciences up 1.47%, Amgen up 0.87%.

ImmunityBio, Inc. is a leading late-stage immunotherapy company focused on activating the innate and adaptive immune systems to treat serious unmet needs in oncology and infectious diseases, with a comprehensive platform of natural killer cell therapies, antibody cytokine fusion proteins, and vaccine vectors.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1151870979"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151870979\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151870979?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-09 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151870979","market":"us","top_or_hot":-1,"title":"Movement Alert｜ImmunityBio, Inc. Rises 5.05% in Regular Trading, Biotechnology Sector Gains on Broad Strength","media":"Market Focus","content":"<p><p>On October 9, ImmunityBio, Inc. rose 5.05% in regular trading, trading at $10.41/share, with turnover of $16.54 million.</p><p>Within the Biotechnology sector where ImmunityBio, Inc. belongs, the overall sector change is positive. Among individual stocks, Moderna up 8.78%, Twist Bioscience up 6.81%, AbbVie up 1.08%, Gilead Sciences up 1.47%, Amgen up 0.87%.</p><p>ImmunityBio, Inc. is a leading late-stage immunotherapy company focused on activating the innate and adaptive immune systems to treat serious unmet needs in oncology and infectious diseases, with a comprehensive platform of natural killer cell therapies, antibody cytokine fusion proteins, and vaccine vectors.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜ImmunityBio, Inc. Rises 5.05% in Regular Trading, Biotechnology Sector Gains on Broad Strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜ImmunityBio, Inc. Rises 5.05% in Regular Trading, Biotechnology Sector Gains on Broad Strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-09 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 9, ImmunityBio, Inc. rose 5.05% in regular trading, trading at $10.41/share, with turnover of $16.54 million.</p><p>Within the Biotechnology sector where ImmunityBio, Inc. belongs, the overall sector change is positive. Among individual stocks, Moderna up 8.78%, Twist Bioscience up 6.81%, AbbVie up 1.08%, Gilead Sciences up 1.47%, Amgen up 0.87%.</p><p>ImmunityBio, Inc. is a leading late-stage immunotherapy company focused on activating the innate and adaptive immune systems to treat serious unmet needs in oncology and infectious diseases, with a comprehensive platform of natural killer cell therapies, antibody cytokine fusion proteins, and vaccine vectors.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IBRX","symbol_name":"ImmunityBio, Inc.","start_time":0,"source_url":"","article_id":"1151870979","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151870979","pubTimestamp":1791554500,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 9, ImmunityBio, Inc. rose 5.05% in regular trading, trading at $10.41/share, with turnover of $16.54 million.Within the Biotechnology sector where ImmunityBio, Inc. belongs, the overall...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IBRX":"ImmunityBio, Inc."},"translate_title":"走势警报|ImmunityBio, Inc. 常规交易中上涨 5.05%，生物技术板块普遍走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBRX":1},"content_text":"On October 9, ImmunityBio, Inc. rose 5.05% in regular trading, trading at $10.41/share, with turnover of $16.54 million.Within the Biotechnology sector where ImmunityBio, Inc. belongs, the overall sector change is positive. Among individual stocks, Moderna up 8.78%, Twist Bioscience up 6.81%, AbbVie up 1.08%, Gilead Sciences up 1.47%, Amgen up 0.87%.ImmunityBio, Inc. is a leading late-stage immunotherapy company focused on activating the innate and adaptive immune systems to treat serious unmet needs in oncology and infectious diseases, with a comprehensive platform of natural killer cell therapies, antibody cytokine fusion proteins, and vaccine vectors.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}